A breakthrough in the treatment of gonorrhoea?
Regularly testing for STIs continues to be essential.
Gonorrhoea is a common STI that is generally fairly quick and easy to treat. However, a rise in cases of antibiotic-resistant gonorrhoea have been worrying health officials around the world.
But the development of a new antibiotic treatment for gonorrhoea - the first advance in treatment for three decades - looks like an effective tool to combat this issue.
The results of a new study - recently published in the Lancet medical journal - suggests that an antibiotic called gepotidacin could be effectively used to treat drug-resistant cases of gonorrhoea. Gepotidacin is currently used to treat urinary tract infections.
An additional benefit of gepotidacin is that it can be taken as a pill, as opposed to an injection. This improves the patient experience but also requires less healthcare resources for the treatment to be delivered.
Gonorrhoea is one of the STIs routinely tested for by sexual health services. The infection is caused by a bacteria that is easily transmitted during a sexual encounter. Wearing a condom doesn't really provide you with any material protection against transmission.
You may be carrying the bacteria and not experiencing any symptoms - that's why regular testing for STIs is important as it helps to identify and treat cases as well as minimising transmission between sexual partners.
The NSFW edition
If you want to admire some man-on-man action, our NSFW edition gives you every inch.
Sign in and check out our NSFW content - it's free!
Gaydar
